The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS NO.: 106685-41-0;methyl 6-(3-(adamantan-1-yl)-4-methoxyphenyl)-2-naphthoate. PROPERTIES: This adamantane methoxy naphthoate presents as a white crystalline solid with a molecular weight of approximately 428.5 g/mol. The methyl 6-(3-(adamantan-1-yl)-4-methoxyphenyl)-2-naphthoate combines an adamantane group with methoxyphenyl and naphthoate functionalities. It exhibits limited aqueous solubility but good dissolution in organic solvents like ethyl acetate and methanol. Stability characterization reveals sensitivity to light exposure and acid-catalyzed demethylation, necessitating storage at 2-8 degree Celsius in amber glass containers. Handlers should use powder hoods with HEPA filtration and wear cut-resistant gloves during handling. Skin contact may cause mild irritation requiring thorough washing. Inhalation may induce respiratory tract irritation; treatment includes fresh air and medical evaluation. Eye exposure requires extended rinsing and possible corticosteroid application. Waste should be hydrolyzed with dilute acid prior to disposal. APPLICATIONS: The methyl 6-(3-(adamantan-1-yl)-4-methoxyphenyl)-2-naphthoate serves as a key intermediate in the synthesis of various pharmaceuticals. Its adamantane methoxyphenyl framework provides opportunities for constructing antiviral agents and metalloenzyme inhibitors. Research teams utilize this compound as a starting material for creating neuraminidase inhibitors and matrix metalloproteinase inhibitors. The naphthoate ester undergoes hydrolysis to carboxylic acids or reduction to alcohols for further functionalization. Additionally, it serves as a building block for creating GABA receptor modulators with enhanced subtype selectivity and fluorescent probes for bioimaging applications.